Allogene Therapeutics, Inc.

Invesco Ltd. ALLO
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/12/2026
Shares
684,519
Value ($000)
1,670
Weight
0.0%
2020 Q1 - 2026 Q1 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).